0000950170-23-066117.txt : 20231127
0000950170-23-066117.hdr.sgml : 20231127
20231127161505
ACCESSION NUMBER: 0000950170-23-066117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231122
FILED AS OF DATE: 20231127
DATE AS OF CHANGE: 20231127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khara Rahul
CENTRAL INDEX KEY: 0001951850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39438
FILM NUMBER: 231440409
MAIL ADDRESS:
STREET 1: C/O DISC MEDICINE, INC.
STREET 2: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Disc Medicine, Inc.
CENTRAL INDEX KEY: 0001816736
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851613057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 674-9274
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE
DATE OF NAME CHANGE: 20210209
FORMER COMPANY:
FORMER CONFORMED NAME: FS Development Corp.
DATE OF NAME CHANGE: 20200702
4
1
ownership.xml
4
X0508
4
2023-11-22
0001816736
Disc Medicine, Inc.
IRON
0001951850
Khara Rahul
C/O DISC MEDICINE, INC.
321 ARSENAL STREET, SUITE 101
WATERTOWN
MA
02472
false
true
false
false
General Counsel
true
Common Stock
2023-11-22
4
M
false
10000
14.69
A
10000
D
Common Stock
2023-11-22
4
S
false
100
50.3400
D
9900
D
Common Stock
2023-11-22
4
S
false
9900
51.7474
D
0
D
Stock Option (Right to Buy)
14.69
2023-11-22
4
M
false
10000
0
D
2032-02-06
Common Stock
10000
79804
D
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.27 to $52.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Rahul Khara
2023-11-27